TIMP metallopeptidase inhibitor 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to hormone | ||
| negative regulation of endopeptidase activity | ||
| negative regulation of endopeptidase activity | ||
| response to cytokine | ||
| response to cytokine |
| GO Term | Evidence Code | PMID |
|---|---|---|
| basement membrane | ||
| basement membrane | ||
| extracellular space | ||
| extracellular space | ||
| extracellular space |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| cytokine activity | ||
| cytokine activity | ||
| protein binding | ||
| growth factor activity |
| InterPro |
|---|
| Netrin domain |
| Protease inhibitor I35 (TIMP) |
| Proteinase inhibitor I35b (TIMP), C-terminal |
| Tissue inhibitor of metalloproteinases-like, OB-fold |
| Location | References |
|---|---|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:90 | degenerative disc disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026